Last updated 2026-08-19
- Raised $17M Secondary led by Amarin Corporation plc, Dec 2007
- Raised $10M Seed round led by Yissum, 1997
Total raised
$27.0M
Stage
—
Founded
1997
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology
Registrar ID: 512495961 (Ester Neurosciences Limited)
About
Ester Neurosciences Ltd. was an Israeli startup focused on developing therapeutic products for neurological disorders such as myasthenia gravis, Alzheimer's disease, multiple sclerosis, and acute stress reactions. Their lead product candidate, EN101, was in Phase IIa clinical development for the treatment of myasthenia gravis. The company utilized a platform messenger RNA (mRNA) silencing technology targeting the cholinergic pathway. Ester Neurosciences was acquired by Amarin Corporation plc in December 2007.
Funding history · 2 rounds · $27.0M total
2 events/rounds · $27.0M Total Funding: $27.0M in Private Equity
Dec 2007
1997
Offices
Tel Aviv, Israel · HQ / main office
Q&A
- What was Ester Neurosciences Ltd.'s primary focus?
- Ester Neurosciences Ltd. was an Israeli startup focused on developing therapeutic products for neurological disorders such as myasthenia gravis, Alzheimer's disease, multiple sclerosis, and acute stress reactions.
- When was Ester Neurosciences Ltd. founded?
- Ester Neurosciences Ltd. was founded in 1997.
- What was the status of Ester Neurosciences Ltd.'s lead product candidate, EN101?
- Ester Neurosciences Ltd.'s lead product candidate, EN101, was in Phase IIa clinical development for the treatment of myasthenia gravis.
- What technology did Ester Neurosciences Ltd. utilize?
- Ester Neurosciences Ltd. utilized a platform messenger RNA (mRNA) silencing technology targeting the cholinergic pathway.
- When and for how much was Ester Neurosciences Ltd. acquired?
- Ester Neurosciences Ltd. was acquired in December 2007 for $30,000,000.
- Who acquired Ester Neurosciences Ltd.?
- Ester Neurosciences Ltd. was acquired by Amarin Corporation plc.
- What was the total amount of funding raised by Ester Neurosciences Ltd.?
- Ester Neurosciences Ltd. raised a total of $40,000,000 across its funding rounds.
- Which investors participated in Ester Neurosciences Ltd.'s Seed round?
- The Seed round for Ester Neurosciences Ltd. included investors such as Yissum.
- Who were the lead investors in Ester Neurosciences Ltd.'s Secondary funding round?
- The Secondary funding round for Ester Neurosciences Ltd. had lead investors including Yissum.
Team · 2
Prof. Hermona Soreq
Founder · CSO
Eli Hazum
CEO
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
Biopharmaceutical
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Ester Neurosciences Limited |
|---|---|
| Founded | 1997 |
Acquisitions & public offerings
Acquired by 2007-12 $30.0M
Radar intelligence
Patents
| EPO | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512495961 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1997-06-17 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | קויפמן יחזקאל 2 תל אביב - יפו |